Cleveland Clinic, one of the world’s top heart hospitals, has launched a new two-part partnership with Ohio-based DASI Simulations. 

A new acellular tissue-engineered vessel developed by Vascudyne could provide surgeons with a safe, effective alternative to saphenous vein grafts.

Several U.S. medical societies have collaborated on a new report advocating for better safety standards in cardiac catheterization labs. As one cardiologist described it, clinicians have shifted from "accepting risk" to "expecting better."

A new clinical trial investigated the safety and efficacy of the procedure, along with its impact on urinary incontinence, erectile dysfunction and other factors. 

Targeting key cardiovascular risk factors for two full years was not linked to a reduced risk of cognitive decline or dementia.

The OmniaSecure defibrillation lead from Medtronic is already approved for placement in the right ventricle. This latest approval covers the left bundle branch area, opening the door for conduction system pacing and other advanced techniques.

The COVID-19 pandemic created a major shift in how telehealth services were being utilized. Those services were used much more often for some patient populations than others.

When patients without diabetes land in the hospital after a heart attack or stroke, early treatment with tirzepatide may prove beneficial.